Cellectis S.A. (CLLS) Social Stream
CELLECTIS SA (CLLS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CELLECTIS SA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-06 | 6 | $33 | $10 | $21.666 | $3.04 | 612.7% |
| 2021-12-22 | 6 | $33 | $10 | $21.25 | $3.04 | 599.01% |
| 2022-03-11 | 7 | $33 | $10 | $20.2 | $3.04 | 564.47% |
| 2022-05-16 | 6 | $33 | $7 | $18 | $3.04 | 492.11% |
| 2022-05-18 | 6 | $33 | $7 | $18 | $3.04 | 492.11% |
| 2022-05-24 | 7 | $33 | $2 | $15.714 | $3.04 | 416.91% |
| 2022-08-09 | 7 | $33 | $2 | $15 | $3.04 | 393.42% |
| 2022-09-23 | 7 | $36 | $2 | $17.625 | $3.04 | 479.77% |
| 2022-11-04 | 7 | $36 | $2 | $17.25 | $3.04 | 467.43% |
| 2022-11-08 | 7 | $36 | $2 | $14.428 | $3.04 | 374.61% |
| 2022-12-14 | 6 | $24 | $2 | $12.714 | $3.04 | 318.22% |
| 2023-03-10 | 4 | $24 | $2 | $11 | $3.04 | 261.84% |
| 2023-03-13 | 6 | $24 | $2 | $9.857 | $3.04 | 224.24% |
| 2023-05-05 | 6 | $16 | $2 | $8.714 | $3.04 | 186.64% |
| 2023-05-12 | 6 | $16 | $2 | $8.4 | $3.04 | 176.32% |
| 2023-11-08 | 4 | $16 | $5 | $9.5 | $3.04 | 212.5% |
| 2023-11-22 | 4 | $11 | $5 | $8 | $3.04 | 163.16% |
| 2023-11-29 | 6 | $11 | $3 | $7.5 | $3.04 | 146.71% |
The Trend in the Analyst Price Target
CLLS's average price target has moved down $28.28 over the prior 43 months.
Over the past 50 weeks, CLLS's average upside potential has been 386.56%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-14 | 5 | 24 | 2 | 12.166 | 2.20 | 453% |
| 2022-12-14 | 6 | 24 | 2 | 12.714 | 2.20 | 477.91% |
| 2023-03-13 | 5 | 24 | 2 | 10.500 | 1.96 | 435.71% |
| 2023-04-05 | 6 | 16 | 2 | 8.714 | 1.98 | 340.1% |
| 2023-11-22 | 5 | 11 | 5 | 8.000 | 2.82 | 183.69% |
CLLS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 5 | 0 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 43 months, CLLS's average broker recommendation rating improved by 0.4.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CLLS has a lower variance in analysts' estimates than -2827.66% of all US stocks.
- CLLS has a greater upside potential (average analyst target price relative to current price) than 2764.57% of all US stocks.
- In the context of Healthcare stocks, CELLECTIS SA's average analyst price target is greater than 729.66% of them.
- CELLECTIS SA's number of analysts covering the stock is greater than 2054.88% of stocks in the small market cap category.
Stocks similar to CELLECTIS SA in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ADAP, OTLK, and TTNP.
View All Top Stocks by Price Target
Make investment decisions regarding CLLS using the data that counts. Try POWR Ratings for free.